SG Americas Securities’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-11,681
Closed -$460K 3279
2018
Q3
$460K Buy
+11,681
New +$443K ﹤0.01% 2152

Other funds holding SBIO

SG Americas Securities's SBIO Position: Q4 2018 in Review

SG Americas Securities sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2018, closing a stake of 11,681 shares — an estimated $460K sold.

SG Americas Securities first reported a position in SBIO in Q3 2018 and held it in 1 quarter. The position peaked at $460K in Q3 2018. 48 funds tracked by Wall St. Rank hold SBIO as of Q4 2018.

  • SG Americas Securities reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2018 after selling out during the quarter.
  • SG Americas Securities sold 11,681 ALPS Medical Breakthroughs ETF shares in Q4 2018, an estimated $460K.
  • SG Americas Securities first reported a position in ALPS Medical Breakthroughs ETF in Q3 2018 and held it in 1 quarter.
  • SG Americas Securities's ALPS Medical Breakthroughs ETF position peaked at $460K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2018.

Based on SG Americas Securities's 13F filing for Q4 2018, filed 1 Feb 2019.